{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:09:24Z","timestamp":1792951764124,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Liaoning Provincial Natural Science Foundation Program Doctoral Research Start-up Projects","award":["No. 2026-BS-0570"],"award-info":[{"award-number":["No. 2026-BS-0570"]}]},{"name":"the 2026 National Postdoctoral Researcher Funding Program-Tier B Funding","award":["No. GZB20260929"],"award-info":[{"award-number":["No. GZB20260929"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02363-x","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:58:47Z","timestamp":1790528327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-\u03baB inflammatory signaling"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1242-8792","authenticated-orcid":false,"given":"Dequan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanmeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070738","author":"H Tang","year":"2024","unstructured":"Tang H, Pang X, Li S, Tang L. The double-edged effects of MLN4924: rethinking anti-cancer drugs targeting the neddylation pathway. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14070738.","journal-title":"Biomolecules"},{"issue":"7239","key":"2363_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458(7239):732\u20136.","journal-title":"Nature"},{"issue":"1","key":"2363_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","volume":"37","author":"JE Brownell","year":"2010","unstructured":"Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ, et al. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell. 2010;37(1):102\u201311.","journal-title":"Mol Cell"},{"issue":"9","key":"2363_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","volume":"116","author":"MA Milhollen","year":"2010","unstructured":"Milhollen MA, Traore T, Adams-Duffy J, Thomas MP, Berger AJ, Dang L, et al. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood. 2010;116(9):1515\u201323.","journal-title":"Blood"},{"issue":"2","key":"2363_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12536","volume":"52","author":"W Zhang","year":"2019","unstructured":"Zhang W, Liang Y, Li L, Wang X, Yan Z, Dong C, et al. The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924\/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma. Cell Prolif. 2019;52(2):e12536.","journal-title":"Cell Prolif"},{"key":"2363_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133250","author":"TM Jones","year":"2021","unstructured":"Jones TM, Carew JS, Bauman JE, Nawrocki ST. Targeting NEDDylation as a novel approach to improve the treatment of head and neck cancer. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13133250.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2363_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1533034615588197","volume":"15","author":"J Wan","year":"2016","unstructured":"Wan J, Zhu J, Li G, Zhang Z. Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme. Technol Cancer Res Treat. 2016;15(4):527\u201334.","journal-title":"Technol Cancer Res Treat"},{"key":"2363_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41420-020-00296-w","volume":"6","author":"J Ferris","year":"2020","unstructured":"Ferris J, Espona-Fiedler M, Hamilton C, Holohan C, Crawford N, McIntyre AJ, et al. Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer. Cell Death Discov. 2020;6:61.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2363_CR9","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3892\/mmr.2017.6305","volume":"15","author":"W Zheng","year":"2017","unstructured":"Zheng W, Luo Z, Zhang J, Min P, Li W, Xu D, et al. Neural precursor cell expressed, developmentally downregulated 8\u2011activating enzyme inhibitor MLN4924 sensitizes colorectal cancer cells to oxaliplatin by inducing DNA damage, G2 cell cycle arrest and apoptosis. Mol Med Rep. 2017;15(5):2795\u2013801.","journal-title":"Mol Med Rep"},{"issue":"12","key":"2363_CR10","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1158\/1078-0432.CCR-09-0343","volume":"15","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Rolfe M. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer. Clin Cancer Res. 2009;15(12):3912\u20136.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2363_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ijc.32379","volume":"145","author":"S Zhou","year":"2019","unstructured":"Zhou S, Zhao X, Yang Z, Yang R, Chen C, Zhao K, et al. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma. Int J Cancer. 2019;145(3):763\u201374.","journal-title":"Int J Cancer"},{"issue":"36","key":"2363_CR12","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1073\/pnas.0505767102","volume":"102","author":"JI Toth","year":"2005","unstructured":"Toth JI, Yang SH, Qiao X, Beigneux AP, Gelb MH, Moulson CL, et al. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A. 2005;102(36):12873\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2363_CR13","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-13-0987","volume":"20","author":"JC Godbersen","year":"2014","unstructured":"Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A, et al. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-\u03baB activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res. 2014;20(6):1576\u201389.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2363_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/bjh.13323","volume":"169","author":"RT Swords","year":"2015","unstructured":"Swords RT, Erba HP, DeAngelo DJ, Bixby DL, Altman JK, Maris M, et al. Pevonedistat (MLN4924), a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. Br J Haematol. 2015;169(4):534\u201343.","journal-title":"Br J Haematol"},{"issue":"1","key":"2363_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","volume":"118","author":"DP Xirodimas","year":"2004","unstructured":"Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell. 2004;118(1):83\u201397.","journal-title":"Cell"},{"key":"2363_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050635","author":"D Liu","year":"2024","unstructured":"Liu D, Wu G, Wang S, Zheng X, Che X. Evaluating the role of neddylation modifications in kidney renal clear cell carcinoma: an integrated approach using bioinformatics, MLN4924 dosing experiments, and RNA sequencing. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17050635.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2363_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-023-00545-x","volume":"12","author":"D Liu","year":"2024","unstructured":"Liu D, Che X, Wu G. Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. Biomark Res. 2024;12(1):5.","journal-title":"Biomark Res"},{"issue":"1","key":"2363_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pharmrev.120.000053","volume":"73","author":"SH Barghout","year":"2021","unstructured":"Barghout SH, Schimmer AD. E1 enzymes as therapeutic targets in cancer. Pharmacol Rev. 2021;73(1):1\u201358.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2363_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5(1):11.","journal-title":"Signal Transduct Target Ther"},{"key":"2363_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.07.030","author":"NA Jayab","year":"2024","unstructured":"Jayab NA, Abed A, Talaat IM, Hamoudi R. The molecular mechanism of NF-\u03baB dysregulation across different subtypes of renal cell carcinoma. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.07.030.","journal-title":"J Adv Res"},{"issue":"1","key":"2363_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03206-5","volume":"43","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Yang G, Wang G, Wan J, Zhang Y, Song W, et al. SEC14L3 knockdown inhibited clear cell renal cell carcinoma proliferation, metastasis and sunitinib resistance through an SEC14L3\/RPS3\/NF\u03baB positive feedback loop. J Exp Clin Cancer Res. 2024;43(1):288.","journal-title":"J Exp Clin Cancer Res"},{"key":"2363_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009963","author":"Z Xu","year":"2024","unstructured":"Xu Z, Liu L, Jiang W, Qiu Y, Zhang B, Cheng J, et al. VHL missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009963.","journal-title":"J Immunother Cancer"},{"issue":"35","key":"2363_CR23","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","volume":"37","author":"AM Mendonsa","year":"2018","unstructured":"Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene. 2018;37(35):4769\u201380.","journal-title":"Oncogene"},{"key":"2363_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109320","volume":"118","author":"ZQ Cao","year":"2019","unstructured":"Cao ZQ, Wang Z, Leng P. Aberrant N-cadherin expression in cancer. Biomed Pharmacother. 2019;118:109320.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2363_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188985","volume":"1878","author":"K van Loon","year":"2023","unstructured":"van Loon K, van Breest Smallenburg ME, Huijbers EJM, Griffioen AW, van Beijnum JR. Extracellular vimentin as a versatile immune suppressive protein in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(6):188985.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"2363_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724200","volume":"12","author":"X Tang","year":"2021","unstructured":"Tang X, Sui X, Weng L, Liu Y. SNAIL1: linking tumor metastasis to immune evasion. Front Immunol. 2021;12:724200.","journal-title":"Front Immunol"},{"issue":"1","key":"2363_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189037","volume":"1879","author":"A Garc\u00eda de Herreros","year":"2024","unstructured":"Garc\u00eda de Herreros A. Dual role of Snail1 as transcriptional repressor and activator. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(1):189037.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"1","key":"2363_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold S, Bonavida B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 2014;33(1):62.","journal-title":"J Exp Clin Cancer Res"},{"key":"2363_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acu\u00f1a JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249739.","journal-title":"Int J Mol Sci"},{"key":"2363_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1093990","volume":"13","author":"L He","year":"2022","unstructured":"He L, Kang Q, Chan KI, Zhang Y, Zhong Z, Tan W. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol. 2022;13:1093990.","journal-title":"Front Immunol"},{"issue":"9-10","key":"2363_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.biochi.2005.04.014","volume":"87","author":"M Le Breton","year":"2005","unstructured":"Le Breton M, Cormier P, Bell\u00e9 R, Mulner-Lorillon O, Morales J. Translational control during mitosis. Biochimie. 2005;87(9\u201310):805\u201311.","journal-title":"Biochimie"},{"issue":"7","key":"2363_CR32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","volume":"159","author":"MJ White","year":"2014","unstructured":"White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159(7):1549\u201362.","journal-title":"Cell"},{"issue":"12","key":"2363_CR33","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/0929867323666160318173706","volume":"23","author":"R Ettari","year":"2016","unstructured":"Ettari R, Previti S, Bitto A, Grasso S, Zappal\u00e0 M. Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases. Curr Med Chem. 2016;23(12):1217\u201338.","journal-title":"Curr Med Chem"},{"issue":"7","key":"2363_CR34","doi-asserted-by":"publisher","first-page":"e152681","DOI":"10.1172\/jci.insight.152681","volume":"7","author":"Y Sasaki","year":"2022","unstructured":"Sasaki Y, Arimochi H, Otsuka K, Kondo H, Tsukumo SI, Yasutomo K. Blockade of the CXCR3\/CXCL10 axis ameliorates inflammation caused by immunoproteasome dysfunction. JCI insight. 2022;7(7):e152681.","journal-title":"JCI insight"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02363-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:15:59Z","timestamp":1790583359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02363-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02363-x","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were reviewed and approved by the Animal Experimental Ethics Committee of Dalian Medical University, China, under the approval number AEE24078.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"228"}}